One-month dual antiplatelet therapy post-stent implant benefits high bleeding risk patients

One month of dual antiplatelet therapy (DAPT) following stent implantation in high bleeding risk patients preserves ischaemic benefits and reduces bleeding risk. That's the finding of late breaking research presented in a Hot Line session today at ESC Congress 2021 and published in the New England Journal of Medicine.

source https://medicalxpress.com/news/2021-08-one-month-dual-antiplatelet-therapy-post-stent.html